http://www.acastipharma.com
Acasti Pharma Inc. Company Intro
Acasti Pharma is a biopharmaceutical innovator advancing a potentially best-in-class cardiovascular drug, CaPre® (omega-3 phospholipid), for the treatment of hypertriglyceridemia, a chronic condition affecting an estimated one third of the…
Industry
Healthcare
Acasti Pharma Inc. Headquaters
545, Promenade du Centropolis
Laval,H7T 0A3
Canada
Acasti Pharma Inc. Share price
17 May 2023 12:43 GMT
$0.4900
0.0 (0.95 %)
Acasti Pharma Inc. Market cap
$22.976 M
WMC RANKING
2024
Acasti Pharma Inc. # 333
BiotechnologyLatest Acasti Pharma Inc. News
12 Feb 2024
Acasti Announces Third Fiscal Quarter 2024 Financial Results and Business Highlights
PRINCETON, N.J., Feb. 12, 2024 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Nasdaq: NASDAQ:ACST) (Acasti or the Company), a late-stage, biopharma company...
12 Feb 2024
Acasti Announces Third Fiscal Quarter 2024 Financial Results and Business Highlights
PRINCETON, N.J., Feb. 12, 2024 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Nasdaq: NASDAQ:ACST) (Acasti or the Company), a late-stage, biopharma company...
09 Feb 2024
Il mercato dell'ipertrigliceridemia grave (SHTG) si prepara a un'espansione eccezionale durante il periodo di ...
La dimensione del mercato dell'ipertrigliceridemia grave nell'area 7MM è stata di circa 2,4 miliardi di dollari nel 2022 e si prevede che aumenterà entro...
WMC Market Score
WMC Market to Revenue Score
Acasti Pharma Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Acasti Pharma Inc. | USD | $196 | $10,836 | $-19,678 | $230M | 333 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ 0.00 | 3 |
| ALK-Abello A/S | USD | $3,556,000 | $1,893,000 | $66,000 | $189,400B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Acasti Pharma Inc. Social Followers vs Top 4 Industry Competitors
Acasti Pharma Inc. Post vs Top 4 Industry Competitors
Acasti Pharma Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Acasti Pharma Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Acasti Pharma Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Acasti Pharma Inc. | 0.00 | 0 | 0 | 0 | 0 | 0 | 0 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 70 | 0 | 0 | 39.85 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 100 | 0 | 0 | 51.56 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 80 | 0 | 0 | 100 |
| ALK-Abello A/S | 38.66 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
